July 8, 2020July 8, 2020
Foundation Offers Free Online Memory Screenings
News
To promote brain health, the Alzheimer’s Foundation of America (AFA) is offering free online memory screenings that people can ... Read more
July 6, 2020July 2, 2020
Caregiving Is a Judgment-free Zone
Columns, Treading Dark Waters - a Column by Ray Burow
Caring for a person with Alzheimer’s disease is challenging enough without caustic, inaccurate criticisms leveled against the caregiver. Sadly, ... Read more
July 6, 2020July 6, 2020
AlzeCure Announces Positive Data From Its First Clinical Study of ACD856
News
AlzeCure Pharma announced positive results from its first clinical study of ACD856 for the potential treatment of Alzheimer’s disease. ... Read more
July 1, 2020July 1, 2020
Amylyx Completes Enrollment in PEGASUS Trial of AMX0035 for Alzheimer’s
News
Amylyx Pharmaceuticals announced it has completed enrollment for the Phase 2 clinical trial of AMX0035 for treating Alzheimer’s disease. The placebo-controlled ... Read more
June 29, 2020June 25, 2020
Simple Solutions to Everyday Caregiving Challenges
Columns, Treading Dark Waters - a Column by Ray Burow
Little annoyances often are the most frustrating for caregivers. Well, perhaps they’re not the most frustrating, but those small ... Read more
June 29, 2020June 29, 2020
Investigational Agitation Treatment AXS-05 Named FDA Breakthrough Therapy
News
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Axsome Therapeutics‘ AXS-05, an investigational oral ... Read more
June 24, 2020June 24, 2020
Advanced Imaging Captures Protein Clumps in Neurons at Early Alzheimer Stages
News
Scientists used a new imaging technique to assess the structure of amyloid-beta aggregates — known culprits in Alzheimer’s development — ... Read more
June 22, 2020June 18, 2020
Father’s Day Prompts Memories of My Mom’s Dementia Diagnosis
Columns, Treading Dark Waters - a Column by Ray Burow
Two million men in the United States have been diagnosed with some form of dementia, the most common of ... Read more
June 22, 2020June 22, 2020
Amyloid Clumps Formed on Space Station Affected by Microgravity
News
Experiments on the International Space Station showed gravity affects the formation of amyloids, the pathological tangles of proteins found ... Read more
June 17, 2020June 17, 2020
Anavex 2-73 Trial for Early Alzheimer’s Expanded to Canada, UK
News
Anavex Life Sciences will expand its Phase 2b/3 clinical trial testing the efficacy and safety of Anavex 2-73 (blarcamesine) ... Read more
June 15, 2020June 12, 2020
Let’s Use Alzheimer’s and Brain Awareness Month to Eliminate Brain Freeze
Columns, Treading Dark Waters - a Column by Ray Burow
Think back to your school days. Remember the anticipation that arrived on the first day of June? School dismissed ... Read more
June 15, 2020June 15, 2020
Neurotrope Launches Long-term Trial of Bryostatin-1
News
Neurotrope has announced the launch of a Phase 2 clinical trial to investigate the long-term use of bryostatin-1 for ... Read more

Author Details

Joe Pierce

July 8, 2020July 8, 2020

Foundation Offers Free Online Memory Screenings

News

To promote brain health, the Alzheimer’s Foundation of America (AFA) is offering free online memory screenings that people can participate in from home. The confidential screenings — part of ... Read more

July 6, 2020July 2, 2020

Caregiving Is a Judgment-free Zone

Columns, Treading Dark Waters - a Column by Ray Burow

Caring for a person with Alzheimer’s disease is challenging enough without caustic, inaccurate criticisms leveled against the caregiver. Sadly, it happens, and what’s even sadder is that we caregivers ... Read more

July 6, 2020July 6, 2020

AlzeCure Announces Positive Data From Its First Clinical Study of ACD856

News

AlzeCure Pharma announced positive results from its first clinical study of ACD856 for the potential treatment of Alzheimer’s disease. According to the company, ACD856 showed a good pharmacokinetic profile ... Read more

July 1, 2020July 1, 2020

Amylyx Completes Enrollment in PEGASUS Trial of AMX0035 for Alzheimer’s

News

Amylyx Pharmaceuticals announced it has completed enrollment for the Phase 2 clinical trial of AMX0035 for treating Alzheimer’s disease. The placebo-controlled trial, PEGASUS (NCT03533257), will evaluate the compound’s safety and tolerability ... Read more

June 29, 2020June 25, 2020

Simple Solutions to Everyday Caregiving Challenges

Columns, Treading Dark Waters - a Column by Ray Burow

Little annoyances often are the most frustrating for caregivers. Well, perhaps they’re not the most frustrating, but those small irritants certainly do rank right up there. These challenges don’t ... Read more

June 29, 2020June 29, 2020

Investigational Agitation Treatment AXS-05 Named FDA Breakthrough Therapy

News

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Axsome Therapeutics‘ AXS-05, an investigational oral therapy for the treatment of agitation in people with Alzheimer’s ... Read more

June 24, 2020June 24, 2020

Advanced Imaging Captures Protein Clumps in Neurons at Early Alzheimer Stages

News

Scientists used a new imaging technique to assess the structure of amyloid-beta aggregates — known culprits in Alzheimer’s development — that are present inside nerve cells at early stages of the disease, ... Read more

June 22, 2020June 18, 2020

Father’s Day Prompts Memories of My Mom’s Dementia Diagnosis

Columns, Treading Dark Waters - a Column by Ray Burow

Two million men in the United States have been diagnosed with some form of dementia, the most common of which is Alzheimer’s disease. More than 75% of caregivers in ... Read more

June 22, 2020June 22, 2020

Amyloid Clumps Formed on Space Station Affected by Microgravity

News

Experiments on the International Space Station showed gravity affects the formation of amyloids, the pathological tangles of proteins found in the brains of those with Alzheimer’s disease. Both the ... Read more

June 17, 2020June 17, 2020

Anavex 2-73 Trial for Early Alzheimer’s Expanded to Canada, UK

News

Anavex Life Sciences will expand its Phase 2b/3 clinical trial testing the efficacy and safety of Anavex 2-73 (blarcamesine) for the treatment of early Alzheimer’s disease into Canada and ... Read more